Author Archive
The glycated hemoglobin or HbA1C is a biomarker reflecting the blood glucose (blood sugar) for about three months. Used by doctors to monitor patients with diabetes it may be a new use profile.
Epidemiologists from Baltimore, the Johns Hopkins Bloomberg School of Public Health, have recently shown that the marker would not only be as good as the FPG to predict diabetes risk, but would be more to predict cardiovascular risk.
The team led by Professor Elizabeth Selvin proposes that diabetes is now diagnosed by measurement of HbA1c. These results were obtained in a study among more than 11,000 blacks and Caucasians in the cohort Atherosclerosis Risk in Communities (ARIC) after a follow-up of 14 years on average. Read the rest of this entry »
Posted in 
Tags: 